An Aryl Hydrocarbon Receptor Agonist Amplifies the Mitogenic Actions of Estradiol in Granulosa Cells: Evidence of Involvement of the Cognate Receptors

• Published in: Biology of reproduction 2006-02, Vol.74 (2), p.417-426
• Main Authors: BUSSMANN, Ursula A, BUSSMANN, Leonardo E, BARANAO, J. Lino
• Format: Article
• Language: English
• Subjects: Animals; Aryl Hydrocarbon Hydroxylases - drug effects; Aryl Hydrocarbon Hydroxylases - genetics; Benzoflavones - pharmacology; beta-Naphthoflavone - pharmacology; Biological and medical sciences; Cells, Cultured; Cytochrome P-450 CYP1A1 - drug effects; Cytochrome P-450 CYP1A1 - genetics; Cytochrome P-450 CYP1B1; DNA - biosynthesis; DNA - drug effects; Drug Synergism; Estradiol - pharmacology; Estrogens, Catechol - pharmacology; Female; Follicle Stimulating Hormone - pharmacology; Fundamental and applied biological sciences. Psychology; Granulosa Cells - drug effects; Granulosa Cells - metabolism; Hormone metabolism and regulation; Mammalian female genital system; Mitogens - pharmacology; Rats; Rats, Sprague-Dawley; Receptors, Aryl Hydrocarbon - agonists; Receptors, Aryl Hydrocarbon - antagonists & inhibitors; Receptors, Aryl Hydrocarbon - metabolism; Receptors, Estrogen - drug effects; Receptors, Estrogen - metabolism; RNA, Messenger - drug effects; Transcriptional Activation - drug effects; Vertebrates: reproduction
• ISSN: 0006-3363; 1529-7268
• DOI: 10.1095/biolreprod.105.043901

The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor that, besides mediating toxic responses, may have a central role in ovarian physiology. Studying the actions of AHR ligands on granulosa cells function, we have found that beta-naphthoflavone amplifies the comitogenic actions of FSH and 17beta-estradiol in a dose-dependent manner. This amplification was even greater in cells that overexpress the AHR and was reversed by cotreatment with the AHR antagonist alpha-naphthoflavone, suggesting that this effect is mediated by the AHR. The estrogen receptor is likewise implicated in this phenomenon, because a pure antiestrogen abolished the described synergism. However, the more traditional inhibitory AHR-estrogen receptor interaction was observed on the estrogen response element-driven transcriptional activity. On the other hand, alpha-naphthoflavone inhibited dose-dependently the mitogenic actions of FSH and 17beta-estradiol. Beta-naphthoflavone induced the expression of Cyp1a1 and Cyp1b1 transcripts, two well-characterized AHR-inducible genes that code for hydroxylases that metabolize estradiol to catecholestrogens. Nevertheless, the positive effect of beta-naphthoflavone on proliferation was not caused by increased metabolism of estradiol to catecholestrogens, because these compounds inhibited the hormonally stimulated DNA synthesis. This latter inhibition exerted by catecholestrogens suggests that these hydroxylases would play a regulatory point in granulosa cell proliferation. Our study indicates that AHR ligands modulate the proliferation of rat granulosa cells, and demonstrates for the first time that an agonist of this receptor is able to amplify the comitogenic action of classical hormones through a mechanism that might implicate a positive cross-talk between the AHR and the estrogen receptor pathways. Abstract The AHR agonist beta-naphthoflavone amplifies the mitogenic actions of classical hormones in granulosa cells, providing evidence for involvement of the aryl hydrocarbon and the estrogen receptors.